166 related articles for article (PubMed ID: 3767545)
21. Morphological and functional renal effects of long-term low-dose cyclosporin A treatment in patients with rheumatoid arthritis.
Sund S; Førre O; Berg KJ; Kvien TK; Hovig T
Clin Nephrol; 1994 Jan; 41(1):33-40. PubMed ID: 8137567
[TBL] [Abstract][Full Text] [Related]
22. [Renal biopsy in connection with long-term treatment of psoriasis with cyclosporine].
Zachariae H; Kragballe K; Hansen HE; Marcussen N; Olsen S
Ugeskr Laeger; 1998 Jul; 160(31):4534-8. PubMed ID: 9700311
[TBL] [Abstract][Full Text] [Related]
23. [The role of tubulointerstitial changes in progression of kidney function failure in patients with chronic glomerulonephritis (GN)].
Idasiak-Piechocka I; Krzymański M
Przegl Lek; 1996; 53(5):443-53. PubMed ID: 8754411
[TBL] [Abstract][Full Text] [Related]
24. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
[TBL] [Abstract][Full Text] [Related]
25. Chronic allograft nephropathy: expression and localization of PAI-1 and PPAR-gamma.
Revelo MP; Federspiel C; Helderman H; Fogo AB
Nephrol Dial Transplant; 2005 Dec; 20(12):2812-9. PubMed ID: 16221712
[TBL] [Abstract][Full Text] [Related]
26. Comparison between pre- and posttreatment renal biopsies in children receiving ciclosporine for idiopathic nephrosis.
Habib R; Niaudet P
Clin Nephrol; 1994 Sep; 42(3):141-6. PubMed ID: 7994931
[TBL] [Abstract][Full Text] [Related]
27. Evolution of ciclosporin nephrotoxicity in patients treated for autoimmune uveitis.
Austin HA; Palestine AG; Sabnis SG; Balow JE; Preuss HG; Nussenblatt RB; Antonovych TT
Am J Nephrol; 1989; 9(5):392-402. PubMed ID: 2801787
[TBL] [Abstract][Full Text] [Related]
28. Renal biopsy in patients with unexplained renal impairment and normal kidney size.
Farrington K; Levison DA; Greenwood RN; Cattell WR; Baker LR
Q J Med; 1989 Mar; 70(263):221-33. PubMed ID: 2602535
[TBL] [Abstract][Full Text] [Related]
29. Relationship between alpha-smooth muscle actin expression and fibrotic changes in human kidney.
Boukhalfa G; Desmoulière A; Rondeau E; Gabbiani G; Sraer JD
Exp Nephrol; 1996; 4(4):241-7. PubMed ID: 8864727
[TBL] [Abstract][Full Text] [Related]
30. The kidney in cyclosporin A-treated diabetic patients: a long-term clinicopathological study.
Assan R; Timsit J; Feutren G; Bougnères P; Czernichow P; Hannedouche T; Boitard C; Noel LH; Mihatsch MJ; Bach JF
Clin Nephrol; 1994 Jan; 41(1):41-9. PubMed ID: 8137568
[TBL] [Abstract][Full Text] [Related]
31. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
[TBL] [Abstract][Full Text] [Related]
32. Kidney pathology in liver allograft recipients after long-term treatment with cyclosporin A.
Dische FE; Neuberger J; Keating J; Parsons V; Calne RY; Williams R
Lab Invest; 1988 Apr; 58(4):395-402. PubMed ID: 3282124
[TBL] [Abstract][Full Text] [Related]
33. Histopathologic evaluation of pretransplant biopsy as a factor influencing graft function after kidney transplantation: a 1-year observation.
Sulikowski T; Tejchman K; Domański L; Urasińska E; Kamiński M; Zietek Z; Sieńko J; Romanowski M; Safranow K; Bohatyrewicz R; Ciechanowski K; Ostrowski M
Transplant Proc; 2007 May; 39(4):943-7. PubMed ID: 17524858
[TBL] [Abstract][Full Text] [Related]
34. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy.
Heeringa SF; Branten AJ; Deegens JK; Steenbergen E; Wetzels JF
Nephrol Dial Transplant; 2007 Aug; 22(8):2201-7. PubMed ID: 17442739
[TBL] [Abstract][Full Text] [Related]
35. Treatment of endogenous uveitis with cyclosporine A.
BenEzra D; Cohen E; Rakotomalala M; de Courten C; Harris W; Chajek T; Friedman G; Matamoros N
Transplant Proc; 1988 Jun; 20(3 Suppl 4):122-7. PubMed ID: 3381266
[TBL] [Abstract][Full Text] [Related]
36. Normal renal function 8 to 13 years after cyclosporin A therapy in 285 diabetic patients.
Assan R; Blanchet F; Feutren G; Timsit J; Larger E; Boitard C; Amiel C; Bach JF
Diabetes Metab Res Rev; 2002; 18(6):464-72. PubMed ID: 12469360
[TBL] [Abstract][Full Text] [Related]
37. [Cyclosporin treatment in uveitis].
Quentin CD; Vogel M
Klin Monbl Augenheilkd; 1986 Mar; 188(3):248-50. PubMed ID: 3713099
[TBL] [Abstract][Full Text] [Related]
38. [Acute renal insufficiency in renal transplants treated with interferon-alpha for chronic hepatitis C].
Rostaing L; Modesto A; Baron E; Cisterne JM; Chabannier MH; Tkaczuk J; Durand D; Suc JM
Nephrologie; 1996; 17(4):247-54. PubMed ID: 8768457
[TBL] [Abstract][Full Text] [Related]
39. Effects of long-term cyclosporine A therapy on renal functions in Behçet's disease.
Saricaoglu H; Bulbul EB; Cikman ST; Dilek K; Tunali S
Int J Tissue React; 2004; 26(3-4):93-6. PubMed ID: 15648441
[TBL] [Abstract][Full Text] [Related]
40. Behcet's disease and IgA nephropathy: report of this association in a patient from Brazil and literature review.
Fernandes PF; Júnior GB; Barros FA; Sousa DC; Franco LM; Patrocínio RM
Invest Clin; 2006 Dec; 47(4):405-11. PubMed ID: 17176908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
